TL Genomics Company
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.The company isolates fetal cells in maternal blood using a uniquely developed technology and examines the genome of the fetal cells, enabling noninvasive and definitive diagnosis of fetal chromosomal disease early in pregnancy.
Connections
Total Funding:
$4 M
Headquarters:
Koganei, Tokyo, Japan
Funding Status:
Series B
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Technology:
Pregnancy biomarkers
Last Funding Date:
2018-05-07
Investors Number:
4
Founded Date:
2015-01-01
Industry:
Diagnostics